Needham Maintains Lucid Diagnostics(LUCD.US) With Buy Rating, Maintains Target Price $2.5

Futu NewsMar 21 02:33 · Ratings

Lucid Diagnostics Gains Buy Rating Amidst Clinical and Commercial Advancements

TipRanksMar 21 00:35 · Ratings

Express News | Lucid Diagnostics Announces Updated National Comprehensive Cancer Network® (Nccn) Guidelines Now Include Esophageal Precancer Screening

BreakingsMar 20 20:31

Lucid Diagnostics Announces Updated National Comprehensive Cancer Network (NCCN) Guidelines Now Include Esophageal Precancer Screening

PR NewswireMar 20 20:31

Earnings Preview: LUCD to Report Financial Results Pre-market on March 24

$Lucid Diagnostics(LUCD.US)$ is scheduled to release its financial results pre-market on March 24 ET. Earnings PreviewAnalysts estimate $Lucid Diagnostics(LUCD.US)$ to post revenue of USD1.42M for 202

Futu NewsMar 19 09:00

BTIG Maintains Lucid Diagnostics(LUCD.US) With Buy Rating, Maintains Target Price $2.5

Futu NewsMar 19 02:33 · Ratings

Express News | Lucid Diagnostics' Envet-Be Clinical Utility Study of Esoguard® Esophageal Precancer Testing Accepted for Peer-Reviewed Publication

BreakingsMar 18 20:31

Lucid Diagnostics' ENVET-BE Clinical Utility Study of EsoGuard Esophageal Precancer Testing Accepted for Peer-Reviewed Publication

PR NewswireMar 18 20:31

Healthcare Up as Traders Rotate to Less Inflation-Sensitive Sectors -- Health Care Roundup

Dow JonesMar 18 04:53

Lucid Diagnostics Secures First Positive Commercial Insurance Coverage Policy for Its EsoGuard Esophageal DNA Test

PR NewswireMar 13 19:36

Cantor Fitzgerald Maintains Lucid Diagnostics(LUCD.US) With Buy Rating, Maintains Target Price $2

Futu NewsMar 11 00:32 · Ratings

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on March 24, 2025

PR NewswireMar 10 21:01

Lucid Diagnostics Announces $15.3 Million Registered Direct Offering

PR NewswireMar 4 21:25

Express News | Lucid Diagnostics Inc: Announces $15.3 Million Registered Direct Offering

BreakingsMar 4 21:17

Express News | Lucid Diagnostics Inc - Terminates Atm Prospectus Supplement Dated Dec 6, 2022

BreakingsMar 4 20:58

Lucid Diagnostics Partners With NIH For $8M Study On Esophageal Precancer Detection Using EsoCheck And EsoGuard; 5-Year Clinical Study Involves Case Western Reserve University And University Hospitals

BenzingaFeb 27 21:33

Express News | Renowned Investigators Awarded $8 Million Nih Grant to Study Lucid Diagnostics' Esoguard® in at-Risk Patients Without Symptomatic Gerd

BreakingsFeb 27 21:31

Renowned Investigators Awarded $8 Million NIH Grant to Study Lucid Diagnostics' EsoGuard in At-Risk Patients Without Symptomatic GERD

PR NewswireFeb 27 21:31

Lucid Diagnostics Regains Compliance With Nasdaq Minimum Bid Price Requirement

PR NewswireFeb 25 21:31

Lucid Diagnostics Executes First Concierge Medicine Contract With LEAA Health

PR NewswireFeb 20 21:31